Bicyclic Heterocycles as FGFR Inhibitors
Copyright © Targeted News Service 2024
2024-10-22
ALEXANDRIA, Virginia, Oct. 22 -- INCYTE CORPORATION, Wilmington, Delaware has been assigned a patent (No. US 12122767 B2, initially filed Sept. 30, 2020) developed by three inventors Oleg Vechorkin, Wilmington, Delaware; Hai Fen Ye, Newark, Delaware; and Wenqing Yao, Chadds Ford, Pennsylvania, for "Bicyclic heterocycles as FGFR inhibitors." . . .